Volume 8, Issue 3 (Aug 2020)                   Res Mol Med (RMM) 2020, 8(3): 147-152 | Back to browse issues page


XML Print


1- Department of Biology, Payame Noor University, Tehran, Iran
2- Department of Clinical Biochemistry, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran , dqujeq@gmail.com
3- Gut and Liver Research Center, Mazandaran University of Medical Sciences, Sari, Iran
4- Department of biochemistry, Payame Noor University, Tehran, Iran
Abstract:   (2186 Views)
Background: Currently, glycans, which are known as functional molecules in the biological system, are being under study as potential cancer markers. This study aimed to determine the level of serum L-fucose and sialic acid as the biomarkers in patients with colorectal cancer (CRC).
Materials and Methods: The patients with CRC (n=40, 20 men and 20 women) participated in the present study. The spectrophotometric method was used to measure the levels of L-fucose and sialic acid in the serum of the patients. SPSS (version 21) was used to analyze the obtained data. The results were expressed as mean ± SD.
Results: The mean ± SD L-fucose level in patients with CRC was 27.46 ± 4.8 ng/mL, which was more than this level in the healthy control group (18.64±3.1 ng/mL). Also, the mean ± SD serum concentration of sialic acid in patients with CRC was 2.1 ± 0.41 ng/mL, which was more than the mean ± SD sialic acid level of 1.23±0.21 ng/mL in the healthy controls.
Conclusion: Serum concentration of L-fucose and sialic acid increased significantly (P < 0.05) in patients with CRC compared with the healthy controls. We believe that determining serum L-fucose and sialic acid levels could be useful for the detection of CRC patients in the early stage.
 
Full-Text [PDF 697 kb]   (1130 Downloads)    
Type of Study: Research | Subject: Biochemistry
Published: 2020/07/22

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.